Evidence map›Paper›PMID 25989741›Full record

ArticleScientific reports2015

Predicting disease progression from short biomarker series using expert advice algorithm.

Kai Morino, Yoshito Hirata, Ryota Tomioka, Hisashi Kashima, Kenji Yamanishi, Norihiro Hayashi, Shin Egawa, Kazuyuki Aihara

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Knowledge-Informed Machine Learning for Cancer Diagnosis and Prognosis: A Review.IEEE transactions on automation science and engineering : a publication of the IEEE Robotics and Automation Society · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kai MorinoGraduate School of Information Science and Technology, The University of Tokyo, Tokyo 113-8656, Japan.
Yoshito Hirata1] Graduate School of Information Science and Technology, The University of Tokyo, Tokyo 113-8656, Japan [2] Institute of Industrial Science, The University of Tokyo, Tokyo 153-8505, Japan.
Ryota TomiokaToyota Technological Institute at Chicago, Chicago, Illinois 60637, USA.
Hisashi KashimaGraduate School of Informatics, Kyoto University, Kyoto 606-8501, Japan.
Kenji Yamanishi1] Graduate School of Information Science and Technology, The University of Tokyo, Tokyo 113-8656, Japan [2] CREST, JST, Honcho, Kawaguchi, Saitama 332-0012, Japan.
Norihiro HayashiDepartment of Urology, Jikei University School of Medicine, Tokyo 105-8461, Japan.
Shin EgawaDepartment of Urology, Jikei University School of Medicine, Tokyo 105-8461, Japan.
Kazuyuki Aihara1] Graduate School of Information Science and Technology, The University of Tokyo, Tokyo 113-8656, Japan [2] Institute of Industrial Science, The University of Tokyo, Tokyo 153-8505, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Well-trained clinicians may be able to provide diagnosis and prognosis from very short biomarker series using information and experience gained from previous patients. Although mathematical methods can potentially help clinicians to predict the progression of diseases, there is no method so far that estimates the patient state from very short time-series of a biomarker for making diagnosis and/or prognosis by employing the information of previous patients. Here, we propose a mathematical framework for integrating other patients' datasets to infer and predict the state of the disease in the current patient based on their short history. We extend a machine-learning framework of "prediction with expert advice" to deal with unstable dynamics. We construct this mathematical framework by combining expert advice with a mathematical model of prostate cancer. Our model predicted well the individual biomarker series of patients with prostate cancer that are used as clinical samples.

Indexed as

AlgorithmsBiomarkersDisease ProgressionModels, TheoreticalHumansBiomarkers

Identifiers

PMID25989741
PMCPMC5386184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.